Summary Adolescents and young adults (AYAs, aged 15-39 years at cancer diagnosis) are recognized as a distinct patient group with specific clinical and psychosocial needs requiring tailored care. This article presents the Network of Expertise (NoE) on AYAs with cancer developed through the Joint Action on Network of Expertise to strengthen AYA research and
In this session, we explore what the updated EU Health Technology Assessment (HTA) process means for our community and why patient perspectives are more important than ever. Our recent online event brought together experts and community members to break down the changes, discuss how upcoming assessments of new treatments will be shaped, and highlight
There are over 500,000 young cancer survivors, aged 14-39 living in Europe. Thanks to advancements in medical treatments, the survival rate stands at an encouraging 85% in developed European countries (Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda – PubMed (nih.gov)). However, compared to their peers, survivors of childhood, adolescent
Authors Maria Otth 1,2,3,4,*, Marko Ocokoljic 4,5, Theodora Armenkova 5,6, Irina Ban 5,7, Samira Essiaf 4, Maximilian Hopfgartner 5, Lejla Kameric 5,8, Pamela R Kearns 4,9,10, Georgia Kokkinou 5,11, Carmelo Rizzari 4,12,13, Carina Schneider 5, Katrin Scheinemann 1,3,4 Abstract Cancer in children and adolescents is rare. Therefore, experienced multidisciplinary teams of health care professionals
The 15th CCI Europe Conference was successfully held from May 14 to May 17 in Budapest. CCI Europe Conference was hosted in partnership with SIOP Europe with the participation of 130 attendees. You can revisit and download the available presentations below. Thursday 15 May 2025 Title: CCI Europe hard facts: How CCI-E
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
